Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Transitional Cell

Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.

417 public trials 125 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Transitional Cell trial results

Completed

Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors

NCT02014337

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +39 more
Locations
  • ACRC/Arizona Clinical Research Center Inc. Tucson, Arizona, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Rita Nanda, MD Chicago, Illinois, United States
View Trial Details
Completed

Study of Mocetinostat in Patients With Urothelial Carcinoma Having Inactivating Alterations of Specific Genes

NCT02236195

Conditions
Abnormalities, Multiple, Bone Diseases, Bone Diseases, Developmental, +19 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View all 14 locations
View Trial Details
Completed

Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma

NCT01828736

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +15 more
Locations
  • Cliniques saint Luc - Université Catholique de Louvain Brussels, Belgium
  • CHU de Besançon Besançon, France
  • CHU Hôpital Saint André Bordeaux, France
  • Hôpital Jean Perrin Clermont-Ferrand, France
View all 15 locations
View Trial Details
Completed

Single Agent Abraxane as Second Line Therapy in Bladder Cancer

NCT00683059

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations
  • Juravinski Cancer Centre Hamilton, Ontario, Canada
  • London Regional Cancer Program London, Ontario, Canada
  • Ottawa Regional Cancer Centre Ottawa, Ontario, Canada
  • Sunnybrook Health Sciences Centre Toronto, Ontario, Canada
View Trial Details
Completed

A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

NCT01454089

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +14 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 55 locations
View Trial Details
Completed

Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer

NCT00406068

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +24 more
Locations
  • BCG Oncology Phoenix, Arizona, United States
  • San Diego Clinical Trials San Diego, California, United States
  • Connecticut Urological Research at Grove Hill New Britain, Connecticut, United States
  • University of Miami School of Medicine Miami, Florida, United States
View all 31 locations
View Trial Details

Related conditions